Growth Metrics

ENDRA Life Sciences (NDRA) Shares Outstanding (Weighted Average) (2016 - 2025)

ENDRA Life Sciences has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $2.0 million for Q4 2021.

  • Quarterly Shares Outstanding (Weighted Average) fell 89.34% to $2.0 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2021, down 89.34% year-over-year, with the annual reading at $2.0 million for FY2021, 89.34% down from the prior year.
  • Shares Outstanding (Weighted Average) was $2.0 million for Q4 2021 at ENDRA Life Sciences, down from $40.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $41.7 million in Q2 2021 and troughed at $723335.0 in Q1 2017.
  • The 5-year median for Shares Outstanding (Weighted Average) is $7.4 million (2019), against an average of $12.3 million.
  • Year-over-year, Shares Outstanding (Weighted Average) surged 442.35% in 2018 and then tumbled 89.34% in 2021.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.8 million in 2017, then surged by 63.4% to $4.5 million in 2018, then surged by 66.49% to $7.5 million in 2019, then soared by 155.9% to $19.2 million in 2020, then tumbled by 89.34% to $2.0 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Shares Outstanding (Weighted Average) are $2.0 million (Q4 2021), $40.5 million (Q3 2021), and $41.7 million (Q2 2021).